Triamcinolone Acetonide Injection IP

Trade Name: TriaCure
Available Strength : 40 mg
Available Combination : Triamcinolone Acetonide Injection IP is a corticosteroid used to reduce inflammation, swelling, and allergic reactions in various inflammatory and musculoskeletal conditions.
Packing : vial
Pack Insert/Leaflet : YES
Therapeutic use : Triamcinolone Acetonide Injection IP is a corticosteroid used to reduce inflammation and suppress immune responses in various conditions. It is commonly administered for allergic reactions, arthritis, skin disorders, respiratory diseases, and certain autoimmune conditions, providing relief from pain, swelling, and inflammation by inhibiting inflammatory mediators.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.